Citation: If. Khouri et Mj. Keating, HIGH-DOSE CHEMOTHERAPY FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - ELIGIBILITY, TIMING, AND BENEFIT, Annals of oncology, 9(2), 1998, pp. 131-132
Authors:
KHOURI IF
KEATING M
KORBLING M
PRZEPIORKA D
ANDERLINI P
OBRIEN S
GIRALT S
IPPOLITI C
VONWOLFF B
GAJEWSKI J
DONATO M
CLAXTON D
UENO N
ANDERSSON B
GEE A
CHAMPLIN R
Citation: If. Khouri et al., TRANSPLANT-LITE - INDUCTION OF GRAFT-VERSUS-MALIGNANCY USING FLUDARABINE-BASED NONABLATIVE CHEMOTHERAPY AND ALLOGENEIC BLOOD PROGENITOR-CELL TRANSPLANTATION AS TREATMENT FOR LYMPHOID MALIGNANCIES, Journal of clinical oncology, 16(8), 1998, pp. 2817-2824
Authors:
UENO NT
RONDON G
MIRZA NQ
GEISLER DK
ANDERLINI P
GIRALT SA
ANDERSSON BS
CLAXTON DF
GAJEWSKI JL
KHOURI IF
KORBLING M
MEHRA RC
PRZEPIORKA D
RAHMAN Z
SAMUELS BI
VANBESIEN K
HORTOBAGYI GN
CHAMPLIN RE
Citation: Nt. Ueno et al., ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR POOR-RISK PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 16(3), 1998, pp. 986-993
Authors:
KHOURI IF
ROMAGUERA J
PALMER JL
PUGH WC
KORBLING M
SAMUELS B
GIRALT S
RODRIGUEZ A
PRZEPIORKA D
MCLAUGHLIN P
ANDERSSON B
CLAXTON D
MIRZA N
MEHRA R
HAGEMEISTER F
CABANILLAS F
CHAMPLIN R
Citation: If. Khouri et al., PRELIMINARY-REPORT OF A NEW ACTIVE REGIMEN FOR AGGRESSIVE MANTLE CELLLYMPHOMA, British Journal of Haematology, 102(1), 1998, pp. 240-241
Authors:
DELIMA M
VANBESIEN KW
GIRALT SA
KHOURI IF
MEHRA R
ANDERSSON BS
PRZEPIORKA D
GAJEWSKI JL
KORBLING M
CHAMPLIN RE
Citation: M. Delima et al., BONE-MARROW TRANSPLANTATION AFTER FAILURE OF AUTOLOGOUS TRANSPLANT FOR NON-HODGKINS-LYMPHOMA, Bone marrow transplantation, 19(2), 1997, pp. 121-127
Authors:
VANBESIEN KW
DELIMA M
GIRALT SA
MOORE DF
KHOURI IF
RONDON G
MEHRA R
ANDERSSON BS
DYER C
CLEARY K
PRZEPIORKA D
GAJEWSKI JL
CHAMPLIN RE
Citation: Kw. Vanbesien et al., MANAGEMENT OF LYMPHOMA RECURRENCE AFTER ALLOGENEIC TRANSPLANTATION - THE RELEVANCE OF GRAFT-VERSUS-LYMPHOMA EFFECT, Bone marrow transplantation, 19(10), 1997, pp. 977-982
Authors:
KHOURI IF
PRZEPIORKA D
VANBESIEN K
OBRIEN S
PALMER JL
LERNER S
MEHRA RC
VRIESENDORP HM
ANDERSSON BS
GIRALT S
KORBLING M
KEATING MJ
CHAMPLIN RE
Citation: If. Khouri et al., ALLOGENEIC BLOOD OR MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - TIMING OF TRANSPLANTATION AND POTENTIAL EFFECT OF FLUDARABINEON ACUTE GRAFT-VERSUS-HOST DISEASE, British Journal of Haematology, 97(2), 1997, pp. 466-473
Authors:
KHOURI IF
IPPOLITI C
GAJEWSKI J
PRZEPIORKA D
CHAMPLIN RE
Citation: If. Khouri et al., NEUTROPENIAS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - RESPONSE TO THERAPY WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN, American journal of hematology, 52(4), 1996, pp. 313-315
Authors:
KHOURI IF
KANTARJIAN HM
TALPAZ M
GIRALT S
RIOS MO
HESTER JP
CHAMPLIN RE
DEISSEROTH AB
Citation: If. Khouri et al., RESULTS WITH HIGH-DOSE CHEMOTHERAPY AND UNPURGED AUTOLOGOUS STEM-CELLTRANSPLANTATION IN 73 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA - THE MD ANDERSON EXPERIENCE, Bone marrow transplantation, 17(5), 1996, pp. 775-779
Authors:
VANBESIEN KW
MEHRA RC
GIRALT SA
KANTARJIAN HM
PUGH WC
KHOURI IF
MOON Y
WILLIAMS P
ANDERSSON BS
PRZEPIORKA D
MCCARTHY PL
GAJEWSKI JL
DEISSEROTH AB
CABANILLAS FF
CHAMPLIN R
Citation: Kw. Vanbesien et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR POOR-PROGNOSIS LYMPHOMA - RESPONSE, TOXICITY, AND SURVIVAL DEPEND ON DISEASE HISTOLOGY, The American journal of medicine, 100(3), 1996, pp. 299-307
Authors:
VANBESIEN KW
KHOURI IF
GIRALT SA
MCCARTHY P
MEHRA R
ANDERSSON BS
PRZEPIORKA D
GAJEWSKI JL
BELLARE N
NATH R
ROMAGUERA JE
MCLAUGHLIN P
KORBLING M
DEISSEROTH AB
CABANILLAS FF
CHAMPLIN RE
Citation: Kw. Vanbesien et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT LOW-GRADE LYMPHOMA - THE CASE FOR AGGRESSIVE MANAGEMENT, Journal of clinical oncology, 13(5), 1995, pp. 1096-1102
Authors:
KHOURI IF
KEATING MJ
VRIESENDORP HM
READING CL
PRZEPIORKA D
HUH YO
ANDERSSON BS
VANBESIEN KW
MEHRA RC
GIRALT SA
IPPOLITI C
MARSHALL M
THOMAS MW
OBRIEN S
ROBERTSON LE
DEISSEROTH AB
CHAMPLIN RE
Citation: If. Khouri et al., AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS, Journal of clinical oncology, 12(4), 1994, pp. 748-758
Authors:
SEYMOUR JF
KHOURI IF
CHAMPLIN RE
KEATING MJ
Citation: Jf. Seymour et al., REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA COMPLICATED BY HYPERCALCEMIA TREATED WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION - CASE-REPORT AND REVIEW, American journal of clinical oncology, 17(4), 1994, pp. 360-368
Authors:
PRZEPIORKA D
IPPOLITI C
KOBERDA J
CHAN KW
KHOURI IF
FISCHER HE
HUH YO
ESCUDIER SM
SEONG D
DAVIS M
GAJEWSKI J
VRIESENDORP HM
CHAMPLIN RE
Citation: D. Przepiorka et al., INTERLEUKIN-2 FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER HAPLOIDENTICAL MARROW TRANSPLANTATION, Transplantation, 58(7), 1994, pp. 858-860
Authors:
VANBESIEN KW
KHOURI IF
GIRALT SA
MCCARTHY P
MEHRA R
ANDERSSON BS
PRZEPIORKA D
GAJEWSKI JL
BELLARE N
NATH R
ROMAGUERA JE
MCLAUGHLIN PW
KORBLING M
DEISSEROTH AB
CABANILLAS FF
CHAMPLIN RE
Citation: Kw. Vanbesien et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT LOW-GRADE LYMPHOMA - THE CASE FOR AGGRESSIVE MANAGEMENT, Blood, 84(10), 1994, pp. 10000205-10000205
Authors:
KHOURI IF
SUKI S
VANBESIEN K
MCLAUGHLIN P
VRIESENDORP H
PRZEPIORKA D
ANDERSSON B
GIRALT S
GAJEWSKI J
MEHRA R
CABANILLAS F
DEISSEROTH AB
CHAMPLIN RE
Citation: If. Khouri et al., ETOPOSIDE, CYCLOPHOSPHAMIDE (CY), TOTAL-BODY IRRADIATION (TBI), AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR LOW-GRADE NON-HODGKINS-LYMPHOMA (LGL), Blood, 84(10), 1994, pp. 10000206-10000206
Authors:
FAHMY H
ANDERSSON BS
SAMUELS BI
SWAN F
HAGEMEISTER FB
GIRALT S
VANBESIEN K
MEHRA R
PRZEPIORKA D
GAJEWSKI J
KHOURI IF
BESA P
CABANILLAS F
CHAMPLIN RE
Citation: H. Fahmy et al., RESPONSE TO A DOXORUBICIN HIGH-DOSE ARA-C AND CDDP-BASED REGIMEN (ASHAP) PREDICTS FOR LONG-TERM REMISSION AFTER AUTOLOGOUS MARROW TRANSPLANTATION (ABMT) IN ADVANCED HODGKINS-DISEASE (HD), Blood, 84(10), 1994, pp. 10000708-10000708